# Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

Study · id `cardio:ct-nct04774159` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04774159](<https://clinicaltrials.gov/study/NCT04774159>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04774159

Browse, organ or system: Heart; Blood vessels; Brain  
Browse, condition area: Coronary and vascular disease; Stroke; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 6150 participants.

## Technical summary

Registry record NCT04774159. Randomized; quadruple masking; primary purpose treatment. Start 2021-05-06 (actual); primary completion 2029-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 6150 participants (planned count; ClinicalTrials.gov record NCT04774159, source copy `cardio:ctgov-nct04774159-2026-10-05`, retrieved 2026-10-26)
- Started: 2021-05-06 (actual) (ClinicalTrials.gov record NCT04774159, source copy `cardio:ctgov-nct04774159-2026-10-05`, retrieved 2026-10-26)
- Primary completion: 2029-12 (anticipated) (ClinicalTrials.gov record NCT04774159, source copy `cardio:ctgov-nct04774159-2026-10-05`, retrieved 2026-10-26)
- Completion: 2029-12 (anticipated) (ClinicalTrials.gov record NCT04774159, source copy `cardio:ctgov-nct04774159-2026-10-05`, retrieved 2026-10-26)
- Countries: United States; Australia; Belgium; Brazil; Canada; Ecuador; Germany; Netherlands; Switzerland; United Kingdom (ClinicalTrials.gov record NCT04774159, source copy `cardio:ctgov-nct04774159-2026-10-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04774159-2026-10-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Acronym: LEADER-PAD
- Condition: Peripheral Arterial Disease
- Condition: Atherosclerosis of Extremities
- Condition: Inflammation
- Intervention (Drug): Colchicine 0.5 MG Oral Tablet
- Intervention (Drug): Colchicine-Placebo
- Lead sponsor: Population Health Research Institute
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Colchicine (`cardio:colchicine`)
- Registry lists this organization as the lead sponsor: Population Health Research Institute (`cardio:org-population-health-research-institute`)

## Provenance

Content hash: 01080e3992e01387bbd65e416240d88213d68ffb6e91ec436cc4af8bc7b1a4e8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
